Ligand Pharmaceuticals IncorporatedLigand Pharmaceuticals IncorporatedLigand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

No trades
See on Supercharts
Market capitalization
‪1.41 B‬USD
‪52.15 M‬USD
‪131.31 M‬USD
‪16.60 M‬
Beta (1Y)
1.26

About Ligand Pharmaceuticals Incorporated

CEO
Todd C. Davis
Headquarters
Jupiter
Website
Employees (FY)
58
Founded
1987
ISIN
US53220K5048
FIGI
BBG000BKF014
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LGND is 79.77 USD — it has decreased by 1.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ligand Pharmaceuticals Incorporated stocks are traded under the ticker LGND.
Ligand Pharmaceuticals Incorporated is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Ligand Pharmaceuticals Incorporated has a max estimate of 144.00 USD and a min estimate of 95.00 USD.
LGND earnings for the last quarter are 1.02 USD whereas the estimation was 0.62 USD which accounts for 64.52% surprise. Estimated earnings for the next quarter are 0.66 USD. See more details about Ligand Pharmaceuticals Incorporated earnings.
Ligand Pharmaceuticals Incorporated revenue for the last quarter amounts to ‪32.87 M‬ USD despite the estimated figure of ‪27.22 M‬ USD. In the next quarter revenue is expected to reach ‪25.65 M‬ USD.
Yes, you can track Ligand Pharmaceuticals Incorporated financials in yearly and quarterly reports right on TradingView.
Like other stocks, LGND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ligand Pharmaceuticals Incorporated stock right from TradingView charts — choose your broker and connect to your account.
LGND reached its all-time high on Oct 1, 2018 with the price of 278.62 USD, and its all-time low was 6.60 USD and was reached on Oct 28, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 58.00 employees. See our rating of the largest employees — is Ligand Pharmaceuticals Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ligand Pharmaceuticals Incorporated EBITDA is ‪47.20 M‬ USD, and current EBITDA margin is 35.97%. See more stats in Ligand Pharmaceuticals Incorporated financial statements.